Brazil Potash clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Brazil Potash Corp.
GRO · NYSE American · USD · Market cap $128M · 36 employees
Brazil Potash Corp.
Not yet scoredPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1.65 USD at the 13 Nov 2026 close
- Fair valueUnder review: our model's value is 2.84x the price, above our 1.35x limit.
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.25)
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-13).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Brazil Potash Corp. holds its Distribution at $1.65. The statistical read favours the sellers, held for 138 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 138 days |
| Price at the screen | $1.65 |
| Valuation | N/A trailing · -7.39 forward price to earnings |
| Values screen | Not scored · score 94.0 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 0.31% | Below 33% | Interest-bearing debt is just 0.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 15.53% | Below 33% | Cash held in interest-bearing accounts and securities is 15.5% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Brazil Potash clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.
Brazil Potash clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value under review. Our model's value is 2.84x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets. The average target sits +203% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | -7.4x |
| EPS, trailing | -0.54 |
| EPS, forward | -0.28 |
| Profit margin | 0.0%currently unprofitable |
| Return on equity | -15.8%not currently earning a positive return on equity |
| FCF yield | -10.83% |
| Debt to equity | 0.23minimal debt: a conservative balance sheet |
| Current ratio | 42.20comfortably covers its short-term bills |
| Short interest, float | 0.01% |
| 52-week range | 1.86 - 3.99 |
| Market cap | $128M |
| Employees | 36 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGRO trades on NYSE American (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 8.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 17.4% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.3% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.8% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.7% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.7% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.9% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (3 analysts) rates it strong buy, with a mean price target of $7.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (94). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Brazil Potash AI-Powered X-Ray Transmission Sorting Testing Shows Potential for Higher Production and Longer Mine Life Yahoo Finance · 13 Oct 2026
- Brazil Potash Reduces Upfront Capex with 28-Year Construction & Backup Power Contract Yahoo Finance · 14 Sep 2026
- Brazil’s Government Supports Potash Construction Financing Yahoo Finance · 10 Sep 2026
- Brazil's Supreme Federal Court Issues Favorable Decision for Brazil Potash Yahoo Finance · 21 Aug 2026
- Brazil Potash Reports Full-Project FEED Coverage, Liquidity & Policy Support for Autazes – Quarterly Update Report Exec Edge · 18 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-12 | SENTIENT EXECUTIVE GP III LIMITED | Beneficial Owner of more than 10% of a Class of Security | 3,863,872 | $7,727,744 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-22 | Chuck Fleischmann | Republican | sell | 1K–15K |
| 2026-10-22 | Chuck Fleischmann | Republican | buy | 1K–15K |
| 2026-10-20 | Dave McCormick | Republican | buy | 250K–500K |
| 2026-10-20 | Dave McCormick | Republican | buy | 250K–500K |
| 2026-10-20 | Dave McCormick | Republican | buy | 250K–500K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $2.69 | -21.9% | · | $781 | -21.9% |
| 2 months | $3.07 | -31.6% | · | $684 | -31.6% |
| 3 months | $3.65 | -42.5% | · | $575 | -42.5% |
| 6 months | $2.19 | -4.1% | · | $959 | -4.1% |
| 1 year | $2.02 | +4.0% | · | $1,040 | +4.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GRO does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.